LLY compared with FHTX: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

FHTXFoghorn Therapeutics Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

FHTXFoghorn Therapeutics Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

FHTX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±84.1%▲+14.14%×0.17

May 7 '26±62.5%▼−10.26%×0.16

= impliedLLY realized, solidFHTX realized, hatchedOne scale, both sides: full bar = 85%× = |realized| ÷ impliedSource: market data

Q1 FY26

±13.9%

▼−12.92%

×0.93

Jan 12 '26±84.2%▲+23.64%×0.28

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,362.27· delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

FHTXFoghorn Therapeutics Inc.

1.86▼−11.40%· post 1.86· delayed

After hoursNov 5 '26delayed

Mkt cap$124.7MRevenue$16MQ2 FY26Revenue$31MFY25

Compare

After hoursNov 5 '26delayed

LLYELI Lilly & Co

FHTXFoghorn Therapeutics Inc.

1,371.32▼−3.29%post 1,362.27delayed

Price

1.86▼−11.40%post 1.86delayed

$1.3T

Mkt cap

$124.7M

Q3 FY26$24.4B

Revenue

$16MQ2 FY26

FY25$65.2B

Revenue

$31MFY25

LLY1,371.32▼−3.29%vsFHTX1.86▼−11.40%After hoursNov 5 '26delayed